New York, NY -- (SBWIRE) -- 01/13/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Horizon Pharma Inc (NASDAQ:HZNP), Precision Drilling Corp (USA) (NYSE:PDS), Arca Biopharma Inc (NASDAQ:ABIO), Mitsubishi UFJ Financial Group Inc (ADR) (NYSE:MTU)
Horizon Pharma Inc (NASDAQ:HZNP) showed a volume of 1.43 million shares by the end of last trade whereas the average volume of the stock remained 1.66 million shares. The stock opened the session at $8.62 but then moved to $8.50. At that price, the stock showed a negative performance of -1.05%. Horizon Pharma, Inc. operates as a biopharmaceutical company. It is focused on developing and commercializing medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases.
Will HZNP Get Buyers Even After The Recent Rally? Find Out Here
Precision Drilling Corp (USA) (NYSE:PDS) opened the session at $8.98 and closed the session at $9.18. The stock showed a positive performance of 1.66% in previous trading session. Traded with volume of 1.43 million shares in the prior session and the average volume of the stock remained 1.55 million shares. Precision Drilling Corporation (Precision) is a provider of contract drilling and completion and production services primarily to oil and natural gas exploration and production companies in Canada and the United States. The Company operates in two segments: Contract Drilling Services, and Completion and Production Services. In Canada, the Contract Drilling Services segment includes land drilling services,
For How Long PDS will fight for Profitability? Read This Trend Analysis report
Arca Biopharma Inc (NASDAQ:ABIO) opened the session at $2.07 and closed the session at $1.99. The stock showed a negative performance of -3.40% in previous trading session. Traded with volume of 1.44 million shares in the prior session and the average volume of the stock remained 2.23 million shares. The beta of the stock remained 2.49. ARCA biopharma, Inc. (ARCA) is a biopharmaceutical company. The Company's principal focus is developing genetically-targeted therapies for heart failure and other cardiovascular diseases. ARCA's lead product candidate is Gencaro TM (bucindolol hydrochloride), a pharmacologically beta-blocker and mild vasodilator being developed for the treatment of chronic heart failure (HF).
Why Should Investors Buy ABIO After the Recent Fall? Just Go Here and Find Out
Mitsubishi UFJ Financial Group Inc (ADR) (NYSE:MTU) the stock advanced 1.24% and finished the session at $6.55. Traded with volume of 1.41 million shares in the prior session and the average volume of the stock remained 1.21 million shares. The beta of the stock remained 0.90. Mitsubishi UFJ Financial Group, Inc. is a Japan-based company mainly engaged in the banking business. The Company is also involved in trust banking business, security business, credit card business, leasing business and other businesses.
Will MTU Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)